Gain Therapeutics GANX
NASDAQ GANX
$1.21 +0.01 (+1.27%)
As of: Oct 21, 2026 · 3:26 PM EDT

Gain Therapeutics (GANX) Operating Leases (2020 - 2026)

Updated

Gain Therapeutics (GANX) reported Operating Leases of $156,760 for Q2 2026, up 68.8% from $92,851 a year earlier but down 13.9% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Operating Leases (2020 - 2026) Analysis & Trends

At the end of FY2025, Gain Therapeutics posted Operating Leases of $211,238, up 294.1% from FY2024.

  • Operating Leases has a five-year compound annual growth rate of -12.0% (FY2020 to FY2025).
  • By year, Operating Leases came in at $53,598 in FY2024 (-76.7%), $229,855 in FY2023 (-48.0%), $441,784 in FY2022 (-36.4%) and $695,053 in FY2021 (+73.6%).
  • Five-year quarterly Operating Leases spans a low of $30,589 in Q1 2025 and a high of $695,053 in Q4 2021.
  • Year over year, Operating Leases has now increased in each of the last three quarters, with growth averaging 71.5% over the last eight quarters.
  • The high point for year-over-year Operating Leases in five years was Q1 2026 (growth of 495.4%); the low point was Q1 2025 (a decline of 82.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $182,129 (Q1 2026), $211,238 (Q4 2025) and $65,026 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.26 Bn 1,105.84 Bn 19.71 Bn
2 Johnson & Johnson 618.12 Bn 536.65 Bn 17.26 Bn
3 AbbVie 503.25 Bn 476.36 Bn 12.70 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn
5 Novartis Ag 298.45 Bn 262.44 Bn 11.24 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn
7 Amgen 237.30 Bn 192.70 Bn 7.24 Bn
8 Gilead Sciences 191.35 Bn 165.55 Bn 6.22 Bn
9 Pfizer 169.92 Bn 116.56 Bn 10.94 Bn
10 Gain Therapeutics 51.67 Mn -7.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 156,760.00
Mar 31, 2026 182,129.00
Dec 31, 2025 211,238.00
Sep 30, 2025 65,026.00
Jun 30, 2025 92,851.00
Mar 31, 2025 30,589.00
Dec 31, 2024 53,598.00
Sep 30, 2024 96,222.00
Jun 30, 2024 134,321.00
Mar 31, 2024 177,365.00
Dec 31, 2023 229,855.00
Sep 30, 2023 263,460.00
Jun 30, 2023 330,071.00
Mar 31, 2023 385,922.00
Dec 31, 2022 441,784.00
Sep 30, 2022 468,760.00
Jun 30, 2022 544,765.00
Mar 31, 2022 625,449.00
Dec 31, 2021 695,053.00
Sep 30, 2021 576,456.00
API Access

Gain Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=GANX&period=max&api_key=YOUR_API_KEY